EUVIMEDEUVIMED entdecken
Crossref

Cordycepin inhibits the progression of liver cancer by suppressing the YAP/TAZ pathway

Weiting Li, Anyong Zhang, Rongfeng Song, Zhibin Liu, Songhua Wang, Li-Hua Yao, Wei Jiang

Experimental Animals · 2026

DOI: 10.1538/expanim.26-0075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Animals, 2026. Verfasst von Weiting Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Provincial Key Laboratory of Organic Functional Molecules; Institute of Organic Chemistry, Jiangxi Science and Technology Normal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cordycepin exhibits anti-cancer properties; however, its exact mechanism of action in liver cancer remains to be fully elucidated. In this study, we investigated the effects of cordycepin on liver cancer. Our findings demonstrated that cordycepin effectively suppressed tumor growth in liver cancer models and induced apoptosis in HepG2 cells by upregulating caspase-3 expression and decreasing mitochondrial membrane potential. These effects were primarily associated with the inhibition total mRNA and protein expression of the YAP/TAZ, as well as the increased expression of p21 and p53. Moreover, cordycepin significantly reduced the metastatic and invasive potential of HepG2 cells and downregulated the expression of MMP-2 and MMP-9. These results suggest that YAP plays a crucial role in cordycepin-mediated suppression of HepG2 cell proliferation. In conclusion, our study indicates that cordycepin exerts its anti-tumorigenic effects by modulating cellular proliferation through the downregulation of the YAP/TAZ pathway.

Schlagwörter

Stichwörter der Autor:innen

HepG2 cellYAP/TAZ pathwaycordycepinliver cancer

Autor:innen und Institutionen

  • Jiangxi Provincial Key Laboratory of Organic Functional Molecules; Institute of Organic Chemistry, Jiangxi Science and Technology Normal University.
  • School of Life Science, Jiangxi Science & Technology Normal University.
  • School of Physical Education and Health, Jiangxi Science & Technology Normal University.
  • Jiangxi Cancer Hospital (The Second Affiliated Hospital of Nanchang Medical College), Jiangxi Key Laboratory of Translational Research for Cancer.
  • Jiangxi Biotech Vocational College.
  • Department of Gynecologic Oncology, Jiangxi Maternal and Child Health Hospital.

Zitieren

APA

Li, W., Zhang, A., Song, R., Liu, Z., Wang, S., Yao, L. H., & Jiang, W. (2026). Cordycepin inhibits the progression of liver cancer by suppressing the YAP/TAZ pathway. Experimental Animals. https://doi.org/10.1538/expanim.26-0075

Vancouver

Li W, Zhang A, Song R, Liu Z, Wang S, Yao LH, et al. Cordycepin inhibits the progression of liver cancer by suppressing the YAP/TAZ pathway. Experimental Animals. 2026. doi:10.1538/expanim.26-0075

BibTeX
@article{Li2026,
  author = {Li, Weiting and Zhang, Anyong and Song, Rongfeng and Liu, Zhibin and Wang, Songhua and Yao, Li-Hua and Jiang, Wei},
  title = {Cordycepin inhibits the progression of liver cancer by suppressing the YAP/TAZ pathway},
  journal = {Experimental Animals},
  year = {2026},
  doi = {10.1538/expanim.26-0075}
}
Kostenlos starten →